Earlier this year the USA announced it would end all bilateral health funding to Zimbabwe, and in September the government was left with the impossible task to fill the enormous shortfall. US funding was a substantial part of the country’s health budget.
“US government contributions comprise 54% of national healthcare spending, supporting a range of clinical care, laboratory systems, health workforce, commodities, and community-based programs,” according to Health GAP, the global access project.
Now the country is bracing for severe outbreaks of many diseases including malaria and HIV.

Over the past two decades the US President’s Emergency Plan for AIDS Relief (PEPFAR) has spent over $1.7 billion in Zimbabwe. Under the Trump administration that funding has been significantly wound back and in its place new agreements have been offered to each country.
“Of the 1.3 million Zimbabweans living with HIV, more than 1.2 million are now on life-saving HIV treatment thanks to PEPFAR and support from other donors,” according to a 2023 statement by PEPFAR. But that will now come to an end because the two countries were unable to reach a funding agreement, with Zimbabwe saying the proposal offered encroached on their sovereignty.
Dr Khai Hoan Tram, from the University of Washington, and colleagues modelled how many new HIV infections Zimbabwe would have within a year of all US funding ending, considering infections from the loss of HIV testing, prevention and treatment services. They estimate 75,000 new cases of HIV each year will be the result of a full withdrawal of PEPFAR funding.
“Zimbabwe’s experience illustrates both the achievements of PEPFAR and the risks of an incomplete transition planning,” the researchers conclude. “Although external support has enabled remarkable progress in HIV control, durable epidemic control will ultimately require a gradual increase in country ownership and domestic investment aligned with national fiscal realities… Without careful management of this transition period, short-term disruptions may translate into long-term setbacks for HIV epidemic control.”




